Cargando…

Desvenlafaxine in the treatment of major depressive disorder

Major depressive disorder (MDD) is among the most incapacitating conditions in the world. The emergence of the selective serotonin reuptake inhibitor (SSRI) and serotonin norepinephrine reuptake inhibitors (SNRI) antidepressants has improved the treatment of MDD. Desvenlafaxine succinate (DVS) is th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lourenco, Maria Teresa C, Kennedy, Sidney H
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2009
Materias:	Expert Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695227/ https://www.ncbi.nlm.nih.gov/pubmed/19557107

Ejemplares similares

Duloxetine in the treatment of major depressive disorder
por: Goldstein, David J
Publicado: (2007)

Transdermal selegiline for the treatment of major depressive disorder
por: Lee, Kelly C, et al.
Publicado: (2007)

Augmentation treatment in major depressive disorder: focus on aripiprazole
por: Nelson, J Craig, et al.
Publicado: (2008)

Agomelatine and its therapeutic potential in the depressed patient
por: Kennedy, Sidney H, et al.
Publicado: (2007)

New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine
por: Baune, Bernhard T
Publicado: (2008)

Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults
por: Howland, Robert H
Publicado: (2009)

Desvenlafaxine Versus Placebo in the Treatment of Children and Adolescents with Major Depressive Disorder
por: Atkinson, Sarah, et al.
Publicado: (2018)

Pharmacological Treatment of Bipolar Depression: What are the Current and Emerging Options?
por: Yalin, Nefize, et al.
Publicado: (2020)

The role of duloxetine in the treatment of anxiety disorders
por: De Berardis, Domenico, et al.
Publicado: (2008)

The therapeutic potential of escitalopram in the treatment of panic disorder
por: Townsend, Mark H, et al.
Publicado: (2007)

Venlafaxine in the treatment of panic disorder
por: Katzman, Martin A, et al.
Publicado: (2007)

Indiplon in the treatment of sleep disorders
por: Lankford, Alan
Publicado: (2007)

Recommendations for prostate cancer diagnosis and treatment during COVID-19 outbreak were not followed in Brazil
por: Korkes, Fernando, et al.
Publicado: (2022)

Duloxetine in the treatment of generalized anxiety disorder
por: Norman, Trevor R, et al.
Publicado: (2008)

Quetiapine in the treatment of schizophrenia and related disorders
por: Riedel, Michael, et al.
Publicado: (2007)

Ziprasidone in the treatment of mania in bipolar disorder
por: Nicolson, Stephen E, et al.
Publicado: (2007)

Armodafinil in the treatment of sleep/wake disorders
por: Schwartz, Jonathan RL, et al.
Publicado: (2010)

A Southeast Asia Consensus on the Definition and Management of Treatment-Resistant Depression
por: Tor, Phern Chern, et al.
Publicado: (2022)

A review of ramelteon in the treatment of sleep disorders
por: Neubauer, David N
Publicado: (2008)

Role of pregabalin in the treatment of generalized anxiety disorder
por: Baldwin, David S, et al.
Publicado: (2007)

Desvenlafaxine in major depressive disorder: an evidence-based review of its place in therapy
por: Lieberman, Daniel Z, et al.
Publicado: (2010)

Duloxetine for the treatment of generalized anxiety disorder: a review
por: Khan, Ahsan Y, et al.
Publicado: (2009)

Dexmethylphenidate hydrochloride in the treatment of attention deficit hyperactivity disorder
por: Liu, Feng, et al.
Publicado: (2006)

The treatment of generalized anxiety disorder with pregabalin, an atypical anxiolytic
por: Strawn, Jeffrey R, et al.
Publicado: (2007)

An emerging role for escitalopram in the treatment of obsessive-compulsive disorder
por: Hedges, Dawson W, et al.
Publicado: (2007)

Treatment and prevention of mania in bipolar I disorder: focus on aripiprazole
por: Muzina, David J
Publicado: (2009)

Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents
por: Canitano, Roberto, et al.
Publicado: (2008)

Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia
por: Bishop, Jeffrey R, et al.
Publicado: (2008)

Aripiprazole for the maintenance treatment of bipolar disorder: a review of available evidence
por: McIntyre, Roger S, et al.
Publicado: (2011)

A review of aripiprazole in the treatment of patients with schizophrenia or bipolar I disorder
por: Citrome, Leslie
Publicado: (2006)

Update on quetiapine in the treatment of bipolar disorder: results from the BOLDER studies
por: Gajwani, Prashant, et al.
Publicado: (2007)

Organic or psychological? It does matter!
por: Glina, Flavia Ramos, et al.
Publicado: (2022)

Quetiapine monotherapy for bipolar depression
por: Thase, Michael E
Publicado: (2008)

A review of quetiapine in combination with antidepressant therapy in patients with depression
por: Daly, Ella J, et al.
Publicado: (2007)

Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a review
por: Hammerness, Paul, et al.
Publicado: (2009)

The role of ziprasidone in adjunctive use with lithium or valproate in maintenance treatment of bipolar disorder
por: Bowden, Charles L
Publicado: (2011)

Emerging treatments in the management of bipolar disorder – focus on risperidone long acting injection
por: El-Hage, Wissam, et al.
Publicado: (2010)

A rare complication of endoscopic intervention
por: Hameed, Fawad, et al.
Publicado: (2018)

The genetic basis of major depressive disorder
por: Flint, Jonathan
Publicado: (2023)

Carbamazepine extended-release capsules in bipolar disorder
por: Weisler, Richard H
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_9tvq7l5hhchib8gnpmtfprgfii